Atypical Presentation of Cutaneous Melanoma: A Case Report and Literature Review
Main Article Content
Abstract
Cutaneous melanoma is a malignant neoplasm arising from melanocytes and represents one of the leading causes of mortality from skin cancer due to its high capacity for invasion and metastatic spread. Although its diagnosis is usually based on well-established clinical criteria, such as the ABCDE rule, atypical presentations may occur and can make early recognition difficult, potentially delaying appropriate treatment. We present the case of an adult patient with a pigmented lesion characterized by irregular features and progressive evolution, whose clinical and dermoscopic evaluation raised suspicion for melanoma. Surgical excision of the lesion was performed followed by histopathological analysis, which confirmed the diagnosis of cutaneous melanoma. Microscopic evaluation allowed the determination of tumor thickness and level of invasion, which are essential parameters for staging and prognosis. Management consisted of surgical margin widening according to current oncologic recommendations, with favorable clinical outcomes during follow-up. This case highlights the importance of considering melanoma in the differential diagnosis of pigmented lesions with unusual clinical characteristics and emphasizes the fundamental role of thorough clinical examination, dermoscopy, and histopathological evaluation in establishing an accurate diagnosis. Early detection of melanoma remains a key factor in improving prognosis and reducing mortality associated with this neoplasm.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. American Cancer Society. (2023). Cancer facts & figures 2023. American Cancer Society.
II. Balch, C. M., Gershenwald, J. E., Soong, S. J., Thompson, J. F., Atkins, M. B., Byrd, D. R., ... & Sondak, V. K. (2009). Final version of 2009 AJCC melanoma staging and classification. Journal of Clinical Oncology, 27(36), 6199–6206. https://doi.org/10.1200/JCO.2009.23.4799
III. Clark, W. H., From, L., Bernardino, E. A., & Mihm, M. C. (1969). The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Research, 29(3), 705–727.
IV. Dummer, R., Hauschild, A., Santinami, M., Atkinson, V., & Mandalà, M. (2017). Cutaneous melanoma: ESMO clinical practice guidelines. Annals of Oncology, 28(suppl_4), iv126–iv132. https://doi.org/10.1093/annonc/mdx246
V. Elder, D. E., Massi, D., Scolyer, R. A., & Willemze, R. (2018). WHO classification of skin tumours (4th ed.). International Agency for Research on Cancer.
VI. Gershenwald, J. E., & Scolyer, R. A. (2018). Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Annals of Surgical Oncology, 25(8), 2105–2110.
https://doi.org/10.1245/s10434-018-6513-7
VII. Leiter, U., & Garbe, C. (2008). Epidemiology of melanoma and nonmelanoma skin cancer. Advances in Experimental Medicine and Biology, 624, 89–103. https://doi.org/10.1007/978-0-387-77574-6_8
VIII. Marks, R. (2000). Epidemiology of melanoma. Clinical and Experimental Dermatology, 25(6), 459–463.
https://doi.org/10.1046/j.1365-2230.2000.00718.x
IX. National Comprehensive Cancer Network. (2023). NCCN clinical practice guidelines in oncology: Cutaneous melanoma. NCCN.
X. Rigel, D. S., Friedman, R. J., & Kopf, A. W. (2005). The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. Journal of the American Academy of Dermatology, 34(5), 839–847.
XI. Siegel, R. L., Miller, K. D., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.
https://doi.org/10.3322/caac.21763
XII. Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., ... & Johnson, T. M. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology, 80(1), 208–250.
https://doi.org/10.1016/j.jaad.2018.08.055
XIII. Thomas, N. E., Busam, K. J., From, L., Kricker, A., Armstrong, B. K., Anton-Culver, H., ... & Gruber, S. B. (2014). Tumor-infiltrating lymphocytes and melanoma survival. Journal of Clinical Oncology, 32(5), 488–495.
https://doi.org/10.1200/JCO.2013.51.4508
XIV. Whiteman, D. C., Green, A. C., & Olsen, C. M. (2016). The growing burden of invasive melanoma. Journal of Investigative Dermatology, 136(6), 1161–1163. https://doi.org/10.1016/j.jid.2016.01.035
XV. Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J. J., Cowey, C. L., ... & Robert, C. (2017). Overall survival with combined nivolumab and ipilimumab in advanced melanoma. The New England Journal of Medicine, 377(14), 1345–1356. https://doi.org/10.1056/NEJMoa1709684